EDIT vs PAYC
Editas Medicine Inc (EDIT) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
EDIT currently screens at market cap $375.2M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the EDIT and PAYC stock pages for the full models.
Not investment advice.